Teleflex Inc (TFX) stock

TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3028% below fair value

$155.10+1.95 (+1.27%)

Close on Nov 13, 2026Market cap $6.57BP/E 18.8Yield 0.88%

Teleflex ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Teleflex's ebitda for the twelve months ending Sep 30, 2026 was $421.03M, up 75.6% year over year. For fiscal 2025 it was $296.11M, up 11.7% from the year before. Over ten years it grew -3.9% a year on average. The highest annual figure on record is $865.46M in fiscal 2021.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$296.11M	+11.7%
FY2024	Dec 31, 2024	$265.19M	-34.8%
FY2023	Dec 31, 2023	$406.83M	-44.3%
FY2022	Dec 31, 2022	$730.32M	-15.6%
FY2021	Dec 31, 2021	$865.46M	+33.1%
FY2020	Dec 31, 2020	$650.32M	+0.7%
FY2019	Dec 31, 2019	$645.62M	+20.4%
FY2018	Dec 31, 2018	$536.42M	+0.7%
FY2017	Dec 31, 2017	$532.62M	+18.9%
FY2016	Dec 31, 2016	$447.80M	+1.5%
FY2015	Dec 31, 2015	$441.23M	+7.1%
FY2014	Dec 31, 2014	$411.89M	+20.7%
FY2013	Dec 31, 2013	$341.20M	–
FY2012	Dec 31, 2012	-$2.49M	-100.8%
FY2011	Dec 31, 2011	$326.07M	+1.9%
FY2010	Dec 31, 2010	$320.03M	–

Quarterly ebitda

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$157.01M	–
Q2 FY2026	Jun 30, 2026	$122.64M	-4.2%
Q1 FY2026	Mar 31, 2026	$73.93M	-35.4%
Q4 FY2025	Dec 31, 2025	$67.45M	+506.2%
Q3 FY2025	Sep 28, 2025	-$13.78M	-109.8%
Q2 FY2025	Jun 29, 2025	$128.03M	+7.4%
Q1 FY2025	Mar 30, 2025	$114.42M	–
Q4 FY2024	Dec 31, 2024	$11.13M	–
Q3 FY2024	Sep 29, 2024	$140.60M	–
Q2 FY2024	Jun 30, 2024	$119.19M	–
Q1 FY2024	Mar 31, 2024	-$5.73M	–